Dr. Anil Krishna, Chairmand & MD, Medicover Hospitals discusses IPO plans, strategic expansion in key Indian cities, and commitment to advancing patient care through technology and talent development
- What are the main objectives for raising capital through the upcoming IPO?
The funds raised from the IPO will enable us to accelerate our growth strategy. Our primary goals are to expand hospital infrastructure in metro cities and Tier-2 towns, and strengthening our specialty services such as oncology. This will give us greater financial flexibility to invest in advanced healthcare technologies and make quality care accessible to the patients.
- How do you plan to allocate the IPO proceeds across different areas of the business?
The allocation of IPO proceeds will be directed towards developing new hospitals and upgrading existing facilities which has less than 100 beds. Additionally, Medicover will invest in establishing advanced specialty centers such as cancer care units and robotic surgery platforms. A portion of the funds will also be utilized for debt reduction, aimed at lowering our current liability of approximately ₹1,000 crores. This allocation strategy will support our goal of sustainable expansion while maintaining financial stability.
- Can you share your financial performance trends and profitability for the past 3 years?
Medicover has demonstrated steady growth despite industry challenges. Over the past three years, the company’s revenues have grown at a healthy double-digit CAGR, and operational efficiency has improved through scale and technology integration. For the fiscal year 2025, Medicover is projected to close with a turnover of ₹2,000 crores.
- How are you preparing to meet regulatory and compliance standards as a public company?
We are strengthening our internal audit and compliance functions, implementing best-in-class reporting systems, and ensuring all operations meet SEBI and corporate governance norms. Independent advisors and auditors are already engaged to guide us through this transition. Our goal is not only to meet compliance standards but to establish a culture of transparency and accountability consistent with the expectations of a listed company.
- How will you ensure robust corporate governance and transparency post-IPO?
Transparency is the backbone of patient trust and investor confidence. We will strengthen our board with independent directors, implement clear disclosure practices, and ensure accountability at all levels of the organization.
- How will the IPO proceeds be utilized (e.g., debt reduction, expansion, technology, acquisitions)?
The IPO proceeds will primarily fund expansion in Hyderabad, Bengaluru, and Pune. We will also invest in AI-driven healthcare solutions, advanced cancer care infrastructure, and minimally invasive surgical technologies. Select acquisitions may be considered if they align strategically, with our growth objectives. Additionally, debt reduction remains a key priority.
- What are the key financial and operational growth drivers you see in the next 3–5 years?
Over the next 3–5 years, our key growth drivers will center around strategic expansion and optimization of our existing healthcare infrastructure in high-potential urban markets. Specifically, we plan to significantly expand our current hospital facilities in Bengaluru, Pune, and Hyderabad, cities where we already have a strong presence and see increasing demand for quality healthcare services.
From a financial perspective, this targeted expansion will allow us to achieve greater economies of scale, improve asset utilization, and enhance revenue through increased bed capacity and service lines.
- How do you intend to invest in new hospital infrastructure, technology, and digital healthcare solutions?
Our immediate focus is on the Secunderabad and Kokapet hospitals in Hyderabad, with further capacity expansion at Chandanagar. On the digital side, we are building telemedicine, AI-based diagnostics, and remote monitoring solutions to improve accessibility and clinical outcomes.
- What strategies are in place to attract and retain skilled healthcare professionals to support growth?
We are building a strong clinical culture that prioritizes professional autonomy—clinical decisions are always made by doctors. We are also investing in medical education, research opportunities, and global training programs to position Medicover as a preferred destination for top healthcare talent.
- How do you plan to scale operational efficiency, patient care, and service quality as you expand?
We are standardizing clinical protocols across all hospitals, leveraging digital tools for patient management, and adopting multimodal pain and recovery programs. Guided by patient-first philosophy, we ensure that only necessary services are provided—nothing more, nothing less.
- What are the immediate expansion plans—new hospitals, geographies, or digital health initiatives?
Our expansion plans include inaugurating the Secunderabad hospital is set for inauguration in September 2025, followed by the Kokapet hospital by year-end. Expansion in Bengaluru and Pune is also under active consideration. On the digital front, we are strengthening telemedicine and AI-powered platforms to serve patients beyond physical hospital walls.
